Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11248 Results
7681
Predictors of seeking psychotherapy in primary care patients with high somatic symptom burden
Type: Journal Article
Authors: Amina K. Kuby, Bernd Lowe, Alexandra B. Fabisch, Katharina Piontek, Martin Härter, Hans-Helmut Konig, Meike Shedden-Mora
Year: 2019
Topic(s):
Measures See topic collection
,
Medically Unexplained Symptoms See topic collection
7682
Predictors of timely opioid agonist treatment initiation among veterans with and without HIV
Type: Journal Article
Authors: Jessica J. Wyse, Jonathan L. Robbins, Kathleen A. McGinnis, E. J. Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. T. Korthuis, Julie R. Gaither, Kirsha Gordon, Melissa Skanderson, Declan T. Barry, Stephen Crystal, Amy Justice, Kevin L. Kraemer
Year: 2019
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7684
Predictors of treatment satisfaction among older adults with anxiety in a primary care psychology program
Type: Journal Article
Authors: N. E. Hundt, M. E. Armento, B. Porter, J. A. Cully, M. E. Kunik, M. Stanley
Year: 2013
Publication Place: England
Abstract: Increasing numbers of patients are treated in integrated primary care mental health programs. The current study examined predictors of satisfaction with treatment in patients from a randomized clinical trial of late-life generalized anxiety disorder (GAD) in primary care. Higher treatment satisfaction was associated with receiving CBT rather than enhanced usual care. Treatment credibility, treatment expectancies, social support, and improvements in depression and anxiety symptoms predicted higher treatment satisfaction in the total sample. In the CBT group, only credibility and adherence with treatment predicted satisfaction. This suggests that older patients receiving CBT who believe more strongly in the treatment rationale and follow the therapist's recommendations more closely are likely to report satisfaction at the end of treatment. In addition, this study found that adherence mediated the relationship between treatment credibility and treatment satisfaction. In other words, patients' perceptions that the treatment made sense for them led to greater treatment adherence which then increased their satisfaction with treatment.
Topic(s):
General Literature See topic collection
7685
Predictors of Use and Drop Out From a Web-Based Cognitive Behavioral Therapy Program and Health Community for Depression and Anxiety in Primary Care Patients: Secondary Analysis of a Randomized Controlled Trial
Type: Journal Article
Authors: A. J. Rotondi, B. H. Belnap, S. Rothenberger, R. Feldman, B. Hanusa, B. L. Rollman
Year: 2024
Topic(s):
HIT & Telehealth See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
7686
Predisposing Characteristics, Enabling Factors, and Need as Predictors of Integrated Behavioral Health Utilization
Type: Journal Article
Authors: Kaitlin Lilienthal, Kyle Possemato, Jennifer Funderburk, Michael Wade, April Eaker, Gregory Beehler
Year: 2017
Publication Place: New York
Topic(s):
General Literature See topic collection
7687
Predisposing, enabling and reinforcing factors associated with opioid addiction helping behaviour in tri-state Appalachian counties: application of the PRECEDE-PROCEED model-cross-sectional analysis
Type: Journal Article
Authors: A. H. Wilkerson, M. Sharma, R. E. Davis, P. M. Stephens, R. W. Kim, D. Bhati, V. K. Nahar
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7689
Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment
Type: Journal Article
Authors: P. Binder, N. Messaadi, M. C. Perault-Pochat, S. Gagey, Y. Brabant, P. Ingrand
Year: 2016
Publication Place: England
Abstract: As a form of opioid maintenance treatment, high-dose buprenorphine is increasingly being used in the United States. On the French market since 1996, it is the most commonly prescribed and frequently employed opioid maintenance treatment. For unknown reasons, the brand-name form is used far more often than the generic form (76-24%). The objective was to show that the patients' levels of addiction were differentiated according to the form of buprenorphine currently being used and to their previous experience of a different form. An observational study in 9 sites throughout France used self-assessment questionnaires filled out in retail pharmacies by all patients to whom their prescribed buprenorphine treatment was being delivered. The 151 canvassed pharmacies solicited 879 patients, of whom 724 completed the questionnaires. Participants were statistically similar to non-participants. The patients using the brand-name form subsequent to experience with the generic form exhibited a more elevated addiction severity index and a higher dosage than brand-name form users with no experience of a different form. Compared to generic users, their doses were higher, their was addiction more severe, and their alcohol consumption was more excessive; they were also more likely to make daily use of psychotropic substances. However, the level of misuse or illicit consumption was similar between these groups. Preferring the brand-name buprenorphine form to the generic form is associated with a higher level of severe addiction, a more frequent need for daily psychotropics, and excessive drinking; but the study was unable to show a causal link.
Topic(s):
Opioids & Substance Use See topic collection
7690
Preferences for trauma-related mental health services among Latina immigrants from Central American, South America, and Mexico
Type: Journal Article
Authors: Stacey Ilene Kaltman, Alejandra Hurtado de Mendoza, Felisa A. Gonzales, Adriana Serrano
Year: 2014
Topic(s):
Healthcare Disparities See topic collection
7691
Pregnancy and Naltrexone Pharmacotherapy
Type: Journal Article
Authors: Cresta W. Jones, Mishka Terplan
Year: 2018
Publication Place: United States
Abstract:

A 25-year-old woman, gravida 3 para 2 at 12 weeks of gestation, with two prior cesarean deliveries, presents for prenatal care. She is in treatment for opioid use disorder on extended-release naltrexone injection, with a history of opioid overdose, relapse, and poor treatment adherence on methadone and buprenorphine. She asks, "Is it safe for my baby if I continue on this medication? How will you manage my postoperative pain?"

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7692
Pregnancy and Opioid Pain Medications
Type: Government Report
Authors: Centers for Disease Control and Prevention
Year: 2013
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7693
Pregnancy and the Opioid Epidemic
Type: Journal Article
Authors: A. L. Haycraft
Year: 2018
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7694
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them
Type: Journal Article
Authors: H. B. Apsley, K. Brant, S. Brothers, E. Harrison, E. Skogseth, R. P. Schwartz, A. A. Jones
Year: 2024
Abstract:

BACKGROUND: Women face unique barriers when seeking treatment for substance use disorders, often related to pregnancy and parenting. OBJECTIVES: This study adds to the extant literature by elucidating the pregnancy- and parenting-related barriers women face when initiating or continuing medication for opioid use disorder, specifically. DESIGN: This study is based on qualitative semi-structured interviews. METHODS: Three subgroups participated in semi-structured interviews regarding their experiences (N = 42): women with current or past opioid use disorders who have used or were presently using medication for opioid use disorder, professionals working in substance use disorder treatment programs, and criminal justice professionals. RESULTS: Three parenting-related subthemes were identified: (1) insufficient access to childcare to navigate appointments and meetings, (2) fear of losing custody of, or access to, one's children, and (3) prioritizing one's children's needs before one's own. Three subthemes were identified with regard to pregnancy as a barrier: (1) hesitancy among physicians to prescribe medication for opioid use disorder for pregnant patients, (2) limited access to resources in rural areas, and (3) difficulty navigating a complex, decentralized health system. CONCLUSION: Systemic changes are needed to reduce pregnant and parenting women's barriers to seeking medication for opioid use disorder. These include improved childcare support at both in-patient and outpatient treatment programs, which would assuage women's barriers related to childcare, as well as their fears of losing access to their children if they spend time away from their children for treatment. An additional systemic improvement that may reduce barriers for these women is access to comprehensive, integrated care for their prenatal care, postpartum care, pediatric appointments, and appropriate substance use disorder treatment.; Pregnancy and parenting-related barriers to receiving medication for opioid use disorder: Interview themes from multiple perspectives. Women face unique barriers when seeking treatment for substance use disorders, often related to pregnancy and parenting. This study used one-on-one interviews to learn more about the pregnancy- and parenting-related barriers women face when initiating or continuing medication for opioid use disorder, specifically. Three different groups were interviewed: women with current or past opioid use disorders who have used or were presently using medication for opioid use disorder, professionals working in substance use disorder treatment programs, and criminal justice professionals (N = 42). Three parenting-related themes emerged from the interviews: (1) insufficient access to childcare to navigate appointments and meetings, (2) fear of losing custody of, or access to, one’s children, and (3) prioritizing one’s children’s needs before one’s own. Three pregnancy-related themes emerged from the interviews: (1) hesitancy among physicians to prescribe medication for opioid use disorder for pregnant patients, (2) limited access to resources in rural areas, and (3) difficulty navigating a complex health system. Systemic changes are needed to reduce pregnant and parenting women’s barriers to seeking medication for opioid use disorder. These include improved childcare support at treatment programs, which would assuage women’s barriers related to childcare, as well as their fears of losing access to their children if they spend time away from their children for treatment. An additional systemic improvement that may reduce barriers for these women is access to comprehensive, integrated care for their prenatal care, postpartum care, pediatric appointments, and appropriate substance use disorder treatment.; eng

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7695
Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them
Type: Journal Article
Authors: H. B. Apsley, K. Brant, S. Brothers, E. Harrison, E. Skogseth, R. P. Schwartz, A. A. Jones
Year: 2024
Abstract:

BACKGROUND: Women face unique barriers when seeking treatment for substance use disorders, often related to pregnancy and parenting. OBJECTIVES: This study adds to the extant literature by elucidating the pregnancy- and parenting-related barriers women face when initiating or continuing medication for opioid use disorder, specifically. DESIGN: This study is based on qualitative semi-structured interviews. METHODS: Three subgroups participated in semi-structured interviews regarding their experiences (N = 42): women with current or past opioid use disorders who have used or were presently using medication for opioid use disorder, professionals working in substance use disorder treatment programs, and criminal justice professionals. RESULTS: Three parenting-related subthemes were identified: (1) insufficient access to childcare to navigate appointments and meetings, (2) fear of losing custody of, or access to, one's children, and (3) prioritizing one's children's needs before one's own. Three subthemes were identified with regard to pregnancy as a barrier: (1) hesitancy among physicians to prescribe medication for opioid use disorder for pregnant patients, (2) limited access to resources in rural areas, and (3) difficulty navigating a complex, decentralized health system. CONCLUSION: Systemic changes are needed to reduce pregnant and parenting women's barriers to seeking medication for opioid use disorder. These include improved childcare support at both in-patient and outpatient treatment programs, which would assuage women's barriers related to childcare, as well as their fears of losing access to their children if they spend time away from their children for treatment. An additional systemic improvement that may reduce barriers for these women is access to comprehensive, integrated care for their prenatal care, postpartum care, pediatric appointments, and appropriate substance use disorder treatment.; Pregnancy and parenting-related barriers to receiving medication for opioid use disorder: Interview themes from multiple perspectivesWomen face unique barriers when seeking treatment for substance use disorders, often related to pregnancy and parenting. This study used one-on-one interviews to learn more about the pregnancy- and parenting-related barriers women face when initiating or continuing medication for opioid use disorder, specifically. Three different groups were interviewed: women with current or past opioid use disorders who have used or were presently using medication for opioid use disorder, professionals working in substance use disorder treatment programs, and criminal justice professionals (N = 42). Three parenting-related themes emerged from the interviews: (1) insufficient access to childcare to navigate appointments and meetings, (2) fear of losing custody of, or access to, one’s children, and (3) prioritizing one’s children’s needs before one’s own. Three pregnancy-related themes emerged from the interviews: (1) hesitancy among physicians to prescribe medication for opioid use disorder for pregnant patients, (2) limited access to resources in rural areas, and (3) difficulty navigating a complex health system. Systemic changes are needed to reduce pregnant and parenting women’s barriers to seeking medication for opioid use disorder. These include improved childcare support at treatment programs, which would assuage women’s barriers related to childcare, as well as their fears of losing access to their children if they spend time away from their children for treatment. An additional systemic improvement that may reduce barriers for these women is access to comprehensive, integrated care for their prenatal care, postpartum care, pediatric appointments, and appropriate substance use disorder treatment.; eng

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7696
Pregnant and early parenting Indigenous women who use substances in Canada: A scoping review of health and social issues, supports, and strategies
Type: Journal Article
Authors: L. Allen, L. Wodtke, A. Hayward, C. Read, M. Cyr, J. Cidro
Year: 2023
Abstract:

This study reviews and synthesizes the literature on Indigenous women who are pregnant/early parenting and using substances in Canada to understand the scope and state of knowledge to inform research with the Aboriginal Health and Wellness Centre of Winnipeg in Manitoba and the development of a pilot Indigenous doula program. A scoping review was performed searching ten relevant databases, including one for gray literature. We analyzed 56 articles/documents. Themes include: (1) cyclical repercussions of state removal of Indigenous children from their families; (2) compounding barriers and inequities; (3) prevalence and different types of substance use; and (4) intervention strategies. Recommendations for future research are identified and discussed.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7697
Pregnant and Postpartum Individuals' Knowledge, Attitudes, and Perceptions of Extended-release Buprenorphine for Treatment of Opioid Use Disorder
Type: Journal Article
Authors: M. Lai, J. Bowman, J. Charles, M. C. Smid
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
7698
Pregnant and Postpartum Women and Behavioral Health Integration
Type: Report
Authors: The Academy for Integrating Behavioral Health & Primary Care
Year: 2022
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
,
Financing & Sustainability See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7700
Pregnant women in treatment for opioid use disorder: Material hardships and psychosocial factors
Type: Journal Article
Authors: R. Rose-Jacobs, M. Trevino-Talbot, M. Vibbert, C. Lloyd-Travaglini, H. J. Cabral
Year: 2019
Publication Place: England
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection